Advance Member
|
真實世界的數據看起來像這樣
同樣是康復組 兩個gmt就不一樣94 vs 48
採樣時間年齡組劑量也會影響
50% SARS-CoV-2-neutralizing GMT
• Placebo: 10; HCS: 94
• BNT162b1 (18 – 55 y vs. 65 – 85 y)
o D0: 10 vs. 10
o D21: 29 vs. 12
o D28: 267 vs. 101
o D35: 437 vs. 105
• BNT162b2 (18 – 55 y vs. 65 – 85 y)
o D0: 10 vs. 10
o D21: 14 vs. 12
o D28: 361 vs. 149
o D35: 163 vs. 206
Anti-SARS-CoV-2-spike binding antibody levels
Day 43 (14 d after dose 2)
≥18-<55 y old cohort, GM mean (95% CI) peak levels
• 50 mcg: 189 (173-207)
• 100 mcg: 239 (221-259)
• Convalescent plasma: 48 (38-60)
≥55 y old cohort, GM mean (95% CI) peak levels
• 50 mcg: 153 (135-175)
• 100 mcg: 162 (142-185)
• Convalescent plasma: 48 (38-60)
|